hotspot -WSS

hotspot

author：hotspot 2025-08-12 11:28:08 - browse：9466

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Senate bill would ban some hospital facility fees

knowledge

WSS

The unintended consequences of overturning Roe v. Wade

House panel takes first step toward fixing drug shortages

Medicare to cover more brain scans for Alzheimer’s patients

Information blocking fines are now fair game in health care

Google and Epic fight stronger regulation of AI in health care

Sanders adds drug shortage policies to pandemic preparedness bill

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Drug repurposing or repositioning? The language matters

What happened to the House vote on health price transparency?

Medical leaders decry Supreme Court decision on affirmative action

STAT Virtual Event: The State of Biosimilars: What to Watch

Wildfire smoke exposes gaps in outdoor worker protections

Medicare has a new plan to address drug shortages

As demand for Covid shots wanes, Moderna seeks its next success

The unintended consequences of overturning Roe v. Wade

The high cost of giving birth even with insurance

As digital health tech proliferates, a new institute aims to cut through hype

explore

What happened to the House vote on health price transparency?

Why the quest to eradicate polio has stumbled

Medicare to cover more brain scans for Alzheimer’s patients

David Liu startup to focus on CRISPR delivery

FDA weighs limits of animal data in assessing artificial wombs

STAT Virtual Event: The State of Biosimilars: What to Watch

focus

Wikipedia

knowledge

leisure time